VST News

Latest VST News

• RBC Capital Remains a Buy on Verastem (VSTM)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
• Why Marvell and Vistra Stocks Are Soaring Today – and What Wall Street Sees Next
  Ben Yoffe · Oct 6, 2026
• Analysts Offer Insights on Utilities Companies: Portland GE (POR) and Vistra Corp (VST)
  TipRanks Newsroom · Oct 6, 2026
• Why Is Vistra Stock (VST) Rising Today and What Analysts See Next
  Kirti Tak · Oct 5, 2026
• Sigma, Airbnb, Vodafone, Edison, Vistra: Trending by Analysts
  TipRanks Weekend Auto-Generated Newsdesk · Oct 3, 2026
• Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)
  TipRanks Newsroom · Oct 2, 2026
• Siebert Williams Shank & Co Initiates a Buy Rating on Vistra Corp (VST)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 2, 2026
• Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
  Newswire TipRanks · Sep 25, 2026
• Vistra Corp Completes $1.5 Billion Subordinated Notes Offering
  TipRanks Auto-Generated Newsdesk · Sep 24, 2026
• Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Arrowhead Pharmaceuticals (ARWR)
  TipRanks Newsroom · Sep 24, 2026
• Verastem (VSTM) Receives a Buy from H.C. Wainwright
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 21, 2026
• Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)
  TipRanks Newsroom · Sep 21, 2026
• RBC Capital Keeps Their Buy Rating on Verastem (VSTM)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 18, 2026
• Vistra, Upstart, Waste Management, Corning & Credo Shocker
  TipRanks Weekend Auto-Generated Newsdesk · Sep 12, 2026